Company
OptiBiotix Health PLC
LON:OPTI
OptiBiotix Health Plc is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing and commercialising technologies that modulate the human microbiome – the collective genome of the microbes in the body – the company identifies and develops prebiotic formulations and compounds for use in food ingredients and supplements that can impact on human physiology and metabolism, deriving potential health benefits.
574 stories · page 1 of 6
Optibiotix Health launches GoFigure products on China-based online shop Tmall
Products on offering include the company's weight-management aid SlimBiome
Archive
Small Cap Feast - OptiBiotix Health, and more...
24 October 2022*A corporate client of Hybridan LLP** Arranged by most recent first*** Alphabetically arrangedDish of the dayJoiners:Eastinco Mining (ATN.L) has joined AIM.Leavers:Ted Baker has left the London Stock Exchange.What’s cooking i
Optibiotix to launch Go Figure in Saudi Arabia after regulatory approval
A first purchase order has now been placed by partner Nahdi
OptiBiotix able to assert new health claims in Australia for weight management product
René Kamminga, CEO of the company's main operating subsidiary, called the new health claims an important step forward
OptiBiotix Health expects return on investment in second half and beyond
Sales in the first half were lower than expected but the focus was on building a more robust business for the future, said CEO Stephen O'Hara
OptiBiotix Health to become Europe and Africa distributor of next-generation prebiotic
OptiXOS comes with an active pipeline of customer projects
OptiBiotix Health has taken a significant step towards growth, says analyst
Launching into India expands OptiBiotix’ reach into a substantial and fast-growing market, Cenkos noted
OptiBiotix Health achieves commercial milestone as India rollout begins
The company's partner, Apollo Hospitals & Pharmacies, owns the country's biggest pharmacy chain
OptiBiotix Health says subsidiary signs services agreement with Nutraconnect for Asia Pacific Region
Nutraconnect, a nutraceutical business growth acceleration service headquartered in Singapore, will develop and implement the go-to-market strategy for prebiotics ingredients SlimBiome and LeanBiome
OptiBiotix focused on expanding its roster of larger partners
The human microbiome-focused company is an expert in developing compounds to tackle obesity, cardiovascular disease and diabetes
OptiBiotix Health enhances sports and well-being ranges
"The company has been working to develop new first-generation products like LeanBiome and WellBiome into the sports nutrition and health," Stephen O'Hara, OptiBiotix Health’s chief executive, said
OptiBiotix Health inks sweetener deal with a top ingredients company
It is teaming up with Switzerland's Firmenich to develop products and ingredients based on its SweetBiotix technology
OptiBiotix Health well-positioned to outperform with second-generation products
Cenkos's investment thesis is that OptiBiotix's share price represent fair value for its stakes in SkinBio and ProBiotix, with the underlying OptiBiotix business thrown in for free
Optibiotix Health boosts turnover after floating probiotic division
Cenkos advised investors to 'buy' the stock, saying growth is supported by commercial agreements with large partners and a substantial pipeline of opportunities
OptiBiotix Health demerger complete as ProBiotix Health debuts on Aquis exchange
The focus of the newly-independent business is human microbiome-modulating compounds that tackle cardiovascular disease and other lifestyle conditions
OptiBiotix Health plans separate Aquis listing for ProBiotix Health arm
OptiBiotix shareholders will receive a distribution in specie of ProBiotix shares once the float is completed at the end of this month
OptiBiotix Health makes three key hires as it continues its commercial push
Zac Sniderman is taking on the role of business development and sales director in North America, Shiraz Butt is to be the company’s e-commerce director and Karl Burkitt the marketing director
OptiBiotix continues to grow profits on back of sales push
Gross profit up 36% last year to £1.2mln as prebiotic and probiotic businesses add commercial agreements
Does the Gartner Hype Cycle explain the ebb and flow of the multi-billion dollar human microbiome industry?
In equity research, the hypecycle is used to describe the movement of markets and sectors as well as individual stock
OptiBiotix Health sets out blue-print for next growth phase; hails potential of three key deals
Chief executive Stephen O'Hara and his team provided a comprehensive strategic over of the business progress and plans
OptiBiotix Health says consumer study shows CholBiome effective in reducing cholesterol
The life sciences company said 96% of consumers taking CholBiomeX3 reported a reduction in their total cholesterol levels
OptiBiotix Health: Building on its commercial momentum with a second-generation of microbiome-focused products
OptiBiotix is a pioneer of probiotics and prebiotics that work synergistically with the human microbiome, the ecosystem of bacteria found largely in the gut. Its discoveries have been or are being developed to tackle obesity, cardiovascular
OptiBiotix Health says latest study supports case for LPLDL as an alternative to statins
After six weeks, the study indicated a 28.4% reduction in so-called bad cholesterol.
OptiBiotix Health achieves UK accreditation
The accreditation "supports our commercial strategy of selling final product solutions to partners in the retail channel containing our science-backed pro and prebiotic ingredients," said CEO René Kamminga
OptiBiotix Health inks exclusive deal to supply weight management range to Saudi Arabia's largest pharmacy chain
A store launch of an initial seven products from the OptiBiotix range is planned for the first half of next year
Small Cap Wrap - Altus Strategies, OptiBiotix, Angle and more...
The mining royalty Company generating a diversified and precious metal focused portfolio of assets announces that reverse circulation (RC) drilling has extended the strike length of the FT Prospect by at least 150m, to beyond 3km at the Tab
OptiBiotix expands team with two new appointments
The company said it has appointed Christopher Nother as a part time consultant to support the growth of its LPLDL product, while it has also recruited Taru Jain to its management team to focus on growing sales in Asia
OptiBiotix Health inks agreement to jointly fund and carry out a research project involving its microbiome products
The agreement is with Fondazione Edmund Mach - Centro Ricerca e Innovazione, based in Trento, Italy, and the University of Southampton
OptiBiotix Health says it intends to appoint experienced pharma executive, Christopher Brinsmead as a non-executive director
Brinsmead has worked in the pharmaceutical industry for over 30 years, holding executive leadership roles with ICI, and Zeneca, before becoming chairman of AstraZeneca Pharmaceuticals UK, President of AstraZeneca UK and Ireland
OptiBiotix Health continues to clinch deals as sales pick up
OptiBiotix Health PLC (LON:OPTI) has developed technologies that modulate the human microbiome – the collective genome of the microbes in the body. It has done so by creating microbial strains, compounds and formulations for use in food ing
OptiBiotix Health grants US and Canada licence for LPLDL probiotic
Genuine Health Inc will develop a product that it will submit for sign-off from Health Canada for cardiovascular and other claims
OptiBiotix Health shares lifted by launch of meal replacement products down under
The licensing deal with weight management firm OptiPharm is bearing fruit, with the company launching meal replacement shakes and bars that contain OptiBiotix's OptiBiome technology
OptiBiotix Health appoints head of Quality & Operations
Aneta Zlotkowska will join the AIM-listed life sciences business at the beginning of 2021 and one of her primary objectives will be to attain a British Retail Consortium certification for OptiBiotix
OptiBiotix closes exclusive Singapore deal for cholesterol-lowering product line
OptiBiotix said the agreement was another example of the “increasing number of pharmaceutical companies commercialising CholBiome products into the high value GP, hospital and pharmacy markets”
OptiBiotix Health probiotic included in IBS drug candidate
The company's partner, Seed Health, has been given the regulatory green light to begin trials on a treatment that incorporates Lactobacillus Plantarum LPLDL
Proactive news headlines: OptiBiotix Health, ANGLE, InnovaDerma, HANetf...
A glance at some of the day's highlights from the Proactive Investors newswire
OptiBiotix inks exclusive distribution deal for Slimbiome Medical in Singapore
The deal has been signed with United Italian Trading Corporation, a Singaporean pharmaceutical and medical device distribution firm
OptiBiotix Health eyes profitability as it makes preparations for dual listing
The update was provided alongside the company's interim results, which revealed its health products are gaining significant commercial traction
OptiBiotix Health inks non-exclusive license agreement for SlimBiome Medical with HiLife Vitamins & Herbs Co Inc. in the US
Optibiotix said the signing of the agreement with HiLife is subject to the placing of a trial order and a six month period after which both parties will discuss the terms of the agreement to explore online exclusivity for the USA
OptiBiotix Health subsidiary signs Brazilian distribution deal
Ayalla Marketing, the company’s new partner, will distribute the cholesterol-reducing probiotic, LPLDL, as an ingredient and as four finished products
OptiBiotix inks SweetBiotix sweet fibres agreement
The new partner, whose identity is being kept confidential to protect its launch plans, has been granted an exclusive worldwide licence
OptiBiotix Health eyes broader application for its probiotic products
Next-generation probiotic products are becoming aligned to an emerging concept of live drug biotherapeutic products, according to the company
OptiBiotix Health extends terms of its original exclusive licence agreement for OptiBiome with OptiPharm to include Europe
The terms of the exclusive licence agreement originally granted OptiPharm exclusive use of the OptiBiome trademark in Australia, parts of Asia, New Zealand, Middle East, Gulf States and North America
OptiBiotix Health agrees Australia and New Zealand deal for WellBiome
Maxum Foods already has access to OptiBiotix’s SlimBiome and the OptiBiome products under an earlier manufacturing, supply and profit-sharing agreement
OptiBiotix Health extends North America agreement with Agropur
Agropur already has the rights to weight management range SlimBiome in the US, Canada and Mexico
OptiBiotix Health hails acceleration in top-line growth
OptiBiotix is expecting all of its divisions to break into the black this year
OptiBiotix widens relationship with distributor CTC Group
The number of territories covered by the agreement has been extended, as has the number of products
OptiBiotix Health extends German deal to add gut health product to roster
The company is a specialist in the human microbiome, the ecosystem of bacteria that resides in the gut and on the skin
OptiBiotix Health extends distribution deal with CTC Holding
WellBiome will now be added to the list of products distributed by CTC
OptiBiotix Health signs distribution deal for cholesterol supplement covering Australia, New Zealand, Indonesia and Thailand
Leading this latest leg of the international expansion will be Actial Farmaceutica
OptiBiotix Health launches new fibres, minerals blend for gut microbiome health
WellBiome is an evolution of SlimBiome, a functional ingredient sold in more than 70 countries formulated to support weight loss and weight management
OptiBiotix Health business inks UK distribution deal for two key products
The company has teamed up with Cambridge Commodities
OptiBiotix looking to extend its reach into new application areas
The group’s commercial plans for 2020 are centred on extending its reach into new application areas, including hypertension, immune and cognitive health
OptiBiotix Health signs license agreement for SlimBiome trademark with Bobbi Brown's Evolution_18 and related launch of fibre gummies
Brown who is known for turning a simple makeup line, Bobbi Brown Essentials, into a billion-dollar global brand with Estée Lauder Companies
OptiBiotix sees partnership agreements deliver strong revenue growth
“We anticipate further revenue growth in 2020 as existing deals contribute to full-year revenues," said Stephen O’Hara, the group's chief executive officer
OptiBiotix recognised as "key player" in global human microbiome market
The data from Market Study Report said a "growing sedentary lifestyle, increasing incidence of diabetes and chronic diseases globally" will facilitate market growth over the next four years
OptiBiotix signs exclusive distribution deal with MAXCARE for SlimBiome in Taiwan
The group said MAXCARE was “well placed to educate customers on the benefits and functionality SlimBiome can provide”
OptiBiotix Health enters into distribution agreement covering China and Hong Kong
The agreement grants Pierce exclusive rights to import and commercialise OptiBiotix's SlimBiome weight management ingredient and LPLDL, its cholesterol-lowering probiotic, in China and Hong Kong
OptiBiotix Health signs deal with Smart For Life which will see launch of cookies containing SlimBiome in the USA and Canada
The life sciences group, which is developing compounds to tackle obesity, high cholesterol, diabetes and skincare, said the license is contingent on an annual minimum order quantity and the first order within thirty days of signing the agre
OptiBiotix raises £1mln to scale up and expand product ranges internationally
The money will also be used to expand awareness and presence of the company's existing products in the US market
OptiBiotix agrees contract manufacturing deal with French supplements and nutrition group
The move follows on from a tie-up last week with Denmark’s Fipros, which will produce food additive SlimBiome under license for distribution across the EU.
OptiBiotix ties up contract manufacturing deal with a Danish company
It said this latest commercial accord de-risked the business in the event of a hard Brexit, providing a source of product supply within the EU
Archive
Proactive news snapshot: Gfinity, Bango, FastForward Innovations UPDATE …
A glance at some of the day's highlights from the Proactive Investors newswire
OptiBiotix soars as it inks licence agreement for OptiBiome with Australian group OptiPharm
The deal will grant OptiPharm exclusive use of the OptiBiome brand in over 20 markets including Australia and North America
OptiBiotix Health extends distribution footprint for consumer weight management product with enhanced deal
Its agreement with a distributor called Extensor Robert Buczek to a further 15 Eastern European and Central Asian countries
OptiBiotix Health gains further commercial traction with Gulf states distribution deal
It has inked a one-year deal with Lebanon-based Prosperous Pharma
OptiBiotix Health strikes new deal in Bulgaria
Velinoff Pharma will promote and distribute the CholBiome and CholBiomeX3 brands, which contain the company’s LPLDL probiotic bacteria strain
OptiBiotix Health modifies and extends deal with partner Sacco
Instead of the original profit-sharing arrangement, it now becomes a manufacture and supply deal with pricing discounts for increasing sales volumes
OptiBiotix Health updates on commercial initiatives
Chief among them was the complete evaluation of the ingredients of weight management line SlimBiome to ensure they are generally recognised as safe per US Code 21 CFR 170.30
OptiBiotix Health seals distribution deal for LPLDL in the USA and Canada
Market exclusivity is linked to a six month time to first order and to sales volumes
OptiBiotix signs licencing agreement for inclusion of LPLDL probiotic strain into a yogurt product in Uruguay
Under the agreement, SACCO, which helped develop the yogurt formulation, will supply LPLDL under a non-exclusive licence to Granja Pocha for inclusion into fermented milk products
OptiBiotix Health and partner Agropur announce launch of SlimBiome in North American market
Dr. Fred Narbel, managing director of OptiBiotix's prebiotics division said: “This is a key strategic step In OptiBiotix's commercial development as it grants the company access to the US weight management market"
OptiBiotix extends CTC and Cambridge Commodities distribution agreements
The agreements cover the distribution of SlimBiome, SlimBiome Medical and GoFigure
OptiBiotix says Italian partner has launched cholesterol reduction food supplement in Italy
Partner ALFASIGMA is supporting the new product with an "extensive" marketing campaign
Archive
Proactive news snapshot: OptiBiotix Health, Ncondezi Energy, Live Company, Itaconix …
A glance at some of the day's highlights from the Proactive Investors newswire
OptiBiotix Health says it is aiming to reach profitability this year; mulling NASDAQ listing
“Given high investor and consumer interest in the microbiome in the USA and growing sales the board OptiBiotix has commissioned advisors to explore the potential of a dual NASDAQ listing," said chief executive Stephen O’Hara
OptiBiotix unveils human study showing probiotic “can reduce high blood pressure”
Statistically significant reductions were shown in both systolic and diastolic blood pressure levels as well as cholesterol levels, which was consistent with a UK study in 2017
OptiBiotix Health inks deal with Holland & Barrett to sell weight management product
The retailer, with over 1,300 stores in 16 countries, will stock SlimBiome
OptiBiotix higher as it inks SlimBiome distribution agreement in Germany
The new deal is with Draco Ingredients, a firm focused on the distribution of dairy-based ingredients to the dairy, sports and medical nutrition sectors
OptiBiotix says weight loss technology included in two products launched in India
Anthem BioPharma and Zeon Life Sciences have developed Metalite, a weight management supplement, and Metalite Pro, a high protein meal replacement
OptiBiotix Health subsidiary ProBiotix signs distribution deal for Phillipines with CTC Group unit
ProBiotix will supply CTC Far East Philippines with CholBiome®x3, featuring its cholesterol and blood pressure-reducing probiotic strain Lactobacillus plantarum LPLDL®
OptiBiotix inks new exclusivity agreements for GoFigure and SlimBiome
These agreements are another step in extending the geographical reach and sales of both SlimBiome and products such as GoFigure that contain SlimBiome.
OptiBiotix Health receives line extension to European regulatory sign-off
"This line extension will help us convert the commercial opportunities we are working on into distribution agreements," said Dr Fred Narbel, managing director of OptiBiotix's prebiotics division
OptiBiotix Health appoints Mikkel Hvid-Hansen as European Sales Leader of ProBiotix Health
Hvid-Hansen is joining ProBiotix Health from a position as International Sales Manager from Cell Biotech Int., a Korean probiotic company
OptiBiotix’s ProBiotix has LPLDL affirmed as safe by FDA
The probiotic has been certified 'generally recognised as safe', the highest level of food safety rating in the US
OptiBiotix signs distribution deal for GoFigure products in South Africa
OptiBiotix said the agreement is "another strategic step" to take its GoFigure products to international markets
OptiBiotix Health now looking for commercial deals to translate into profits
The life sciences group has signed 44 commercial deals over the past couple of years, and bosses want to see those translate into higher sales and profits
OptiBiotix continues to see commercial traction for its functional food technology
The latest deal involving its weight management productcovers Australia and New Zealand
Archive
Proactive news snapshot: Kavango Resources, OptiBiotix Health, Cello Health...
A glance at some of the day's highlights from the Proactive Investors newswire